NervGen Pharma Corp. (NGEN) stock
NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.96+0.14 (+7.69%)
Close on Nov 17, 2026Market cap $156.11MP/E –Yield –
NervGen Pharma EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for NervGen Pharma
NervGen Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?